Evening announcement ｜ September 13th these announcements are observed

13.09.2022

On the evening of September 13, many listed companies in Shanghai and Shenzhen issued an announcement. The following is the summary of the First Finance and Economics for some important announcements for investors' reference.

▍ ▍ ▍ ▍

Tianhe Light Energy: Signing 2.121 billion yuan of high -purity silicon material procurement contract

Tianhe Guangneng announced that he signed a high-purity silicon material long single procurement contract with Nangu Group. The contract stipulates that in 2023-2026, the company purchases high-purity silicon raw materials products from Nangu Group. The total purchase amount is 2.21 billion yuan.

Huayou Cobalt: Signing a cooperation framework agreement with Tamsui River Valley Indonesia

Huayou Cobalt announced that recently, the company signed a cooperation framework agreement with the Tamsui River Valley Indonesia. The two parties planned to cooperate with the construction of a high -pressure acid soaking method. Mine supply. This project plans to have an annual production capacity of 60,000 tons of nickel metal. Nickel hydroxide cobalt products (MHP). If the supply of brown iron ore increased, the two parties will consider expanding the production capacity of the project. The two parties will sell MHP products based on their shareholding ratio.

Puli Pharmaceutical: Subsidies signed the "GS-00202 Tablet Strike Strategic Cooperation Framework Agreement"

Puli Pharmaceutical Announcement, Zhejiang Puli Pharmaceutical Co., Ltd. and Gu Sen Pharmaceutical signed the "GS-00202 Dose Entrusted Production Strategic Cooperation Framework Agreement" with Gu Sen Pharmaceutical. People (MAH), the two sides agreed to establish long -term cooperation, using Pully Pharmaceutical to comply with the advantages of the production system of Europe, the United States and domestic CGMP solid agents, and for the clinical batch, verification and commercial approval of Guson Pharmaceuticals for domestic and foreign markets Essence

Huahai Pharmaceutical: Preparation Product Fentgomo Made Capsule obtained the US FDA approval number

Huahai Pharmaceutical announced that the preparation product Fentgomod Capsule was approved by the US FDA. Fengomod Capsule is mainly used to treat multiple sclerosis.

St. Jitang: Tongzi chemical methanol products of all -funded subsidiaries temporarily discontinued production

St. Jitang announced that due to the continued sluggish sales price of methanol products, the price of coal of raw materials has continued to rise. If the production of methanol system is restored, the price of finished products will be inverted and the profit of the product is negative. Tongzi chemical methanol products of all -funded subsidiaries are temporarily discontinued. The subsequent company will decide the time to restore methanol production according to the market price and coal price trend of methanol products.

*ST Garden City: The company's stock revokes the delisting risk warning to suspend trading for one day

*ST Garden City announced that the company's shares revoke the withdrawal risk of delisting. The company's stock will be suspended on September 14, 2022 and resumed trading on September 15, 2022. The company's A -share stock is changed from "*ST Garden City" to "Garden City Gold".

Hot -view creature: all -funded subsidiaries were approved to conduct new crown virus nucleic acid testing

The hot -ora -view biological announcement, the Beijing Hot -Book Medical Inspection Laboratory of the wholly -owned subsidiary of the subordinates through the approval of the Beijing Municipal Health and Health Committee, agreed to carry out the new type of coronary virus nucleic acid testing.

▍ ▍ ▍ ▍

Xiamen Airport: In August

Xiamen Airport released a briefing of transportation production in August. In August, passenger throughput was 928,800, an increase of 74.64%year -on -year; cargo and postal throughput was 19,800 tons, a year -on -year decrease of 1.42%.

Gan and Guangdong Expressway: In August, vehicle traffic service revenue was 316 million yuan

The Gan and Guangdong Expressway announced that the company's vehicle traffic service revenue in August 2022 was 316 million yuan. Since the implementation of the "business reform" policy, the revenue of the traffic includes VAT.

Parker New Materials: Thanks to the prosperity of the aviation and aerospace industry, the net profit in the first three quarters increases by 65% ​​year -on -year

Parker's new material announcement is expected to have a net profit of 351 million yuan in the first three quarters, an increase of about 65%year -on -year. The company belongs to the forging industry. In the first three quarters, it benefited from the prosperity of the aviation and aerospace industry and the market orders were sufficient.

▍ ▍ increase or decrease

Holvo: Shareholders intend to reduce their holdings not exceeding 1.16%of the company's shares

Holvo announced that 6.69%of the shareholders and director Fang Wei planned to reduce its holdings of not over 1.16%of the company's shares.

Xiechuang Data: Shareholders intend to reduce their holdings not exceeding 4.14%of the shares

Xiechuang Data announced in the evening that 4.14%of the shareholders, Jin Tong, planned to reduce their holdings of not more than 8.5571 million shares (accounting for 4.14%of the company's total share capital).

ST Wanlin: Shareholders intend to reduce their holdings not exceeding 2%of the company's shares

ST Wanlin announced that Chen Ming, a shareholder holding 6.48%of the shareholders, plans to reduce its holdings of not exceeding 2%of the company's shares.

Shanghai Friendship: Shanghai Kaibao intends to reduce its holdings not exceeding 3%of the company's shares

Shanghai Friendship announced that Shanghai Kaibao, a 13%shareholder, intends to reduce its holdings of not more than 3%of the company's shares.

Huaxin New Material: Xuzhou Huacheng intends to reduce its holdings not exceeding 2%of the shares

Huaxin New Materials announced that Xuzhou Huacheng, a shareholder holding 6.28%of the shares, plans to reduce its holdings of no more than 2.555 million shares in a centralized bidding or a large transaction method (accounting for 2%of the company's total share capital).

Kangzhong Medical: Two shareholders are integrated to reduce their holdings not exceeding 6%of the company's shares

Kangzhong Medical announced that 13.03%of the shareholders Changcheng Co., Ltd. and 5.03%of the shareholders Jun Lianyu intended to reduce their holdings of a total of not exceeding 6%of the company's shares.

- END -